Reviva Pharmaceuticals
RVPH
RVPH
19 hedge funds and large institutions have $1.65M invested in Reviva Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $2.05M → $1.65M (-$402K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
19
Holding in Top 10
–
Calls
$704K
Puts
$298K
Top Buyers
| 1 | +$133K | |
| 2 | +$115K | |
| 3 | +$73K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$64K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$48K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$92.9K | |
| 3 | -$20K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.32K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.13K |